Literature DB >> 23058312

Quantitative assessment of mitral regurgitation: validation of new methods.

Paaladinesh Thavendiranathan1, Dermot Phelan, James D Thomas, Scott D Flamm, Thomas H Marwick.   

Abstract

Accurate assessment of mitral regurgitation (MR) severity is important for clinical decision making, prognostication, and decisions regarding timing of surgical intervention. The most common method for noninvasive assessment of MR has been with 2-dimensional transthoracic echocardiography, which is often used as a qualitative tool. Several newer noninvasive modalities including 3-dimensional echocardiography, cardiac magnetic resonance imaging, and cardiac computed tomography have also become available for this purpose; however, their role in routine clinical practice is not clearly defined. In this review, we provide an overview of these newer modalities for quantitative assessment of MR severity.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23058312     DOI: 10.1016/j.jacc.2012.05.048

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

Review 1.  Three-Dimensional Echocardiography: Current Status and Real-Life Applications.

Authors:  Victor Chien-Chia Wu; Masaaki Takeuchi
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

Review 2.  Three-dimensional echocardiography of the mitral valve: lessons learned.

Authors:  Francesco Maffessanti; Oana Mirea; Gloria Tamborini; Mauro Pepi
Journal:  Curr Cardiol Rep       Date:  2013-07       Impact factor: 2.931

3.  Cardiac magnetic resonance imaging in patients undergoing percutaneous mitral valve repair with the MitraClip system.

Authors:  Patrick Krumm; Christine S Zuern; Thomas H Wurster; Stefanie Mangold; Bernhard D Klumpp; Andreas Henning; Iris I Mueller; Christiane Bretschneider; Axel Bauer; Ulrich Kramer; Andreas E May
Journal:  Clin Res Cardiol       Date:  2014-01-30       Impact factor: 5.460

Review 4.  What Does 3D Echocardiography Add to 2D Echocardiography in the Assessment of Mitral Regurgitation?

Authors:  Tadafumi Sugimoto; Raluca Dulgheru; Stella Marchetta; Federica Ilardi; Laura Contu; Yun Yun Go; Patrizio Lancellotti
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

5.  Artificial intelligence and automation in valvular heart diseases.

Authors:  Qiang Long; Xiaofeng Ye; Qiang Zhao
Journal:  Cardiol J       Date:  2020-06-22       Impact factor: 2.737

6.  Inlet and outlet valve flow and regurgitant volume may be directly and reliably quantified with accelerated, volumetric phase-contrast MRI.

Authors:  Albert Hsiao; Umar Tariq; Marcus T Alley; Michael Lustig; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2014-02-08       Impact factor: 4.813

7.  Percutaneous Interventions for Secondary Mitral Regurgitation.

Authors:  Mahboob Ali; Satya S Shreenivas; David N Pratt; Donald R Lynch; Dean J Kereiakes
Journal:  Circ Cardiovasc Interv       Date:  2020-08-06       Impact factor: 6.546

8.  How do we use imaging to aid considerations for intervention in patients with severe mitral regurgitation?

Authors:  Randolph P Martin
Journal:  Ann Cardiothorac Surg       Date:  2013-11

Review 9.  Multimodality imaging for the quantitative assessment of mitral regurgitation.

Authors:  Pei G Chew; Katrina Bounford; Sven Plein; Dominik Schlosshan; John P Greenwood
Journal:  Quant Imaging Med Surg       Date:  2018-04

10.  Characterization and quantification of dynamic eccentric regurgitation of the left atrioventricular valve after atrioventricular septal defect correction with 4D Flow cardiovascular magnetic resonance and retrospective valve tracking.

Authors:  Emmeline E Calkoen; Jos J M Westenberg; Lucia J M Kroft; Nico A Blom; Mark G Hazekamp; Marry E Rijlaarsdam; Monique R M Jongbloed; Albert de Roos; Arno A W Roest
Journal:  J Cardiovasc Magn Reson       Date:  2015-02-19       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.